Vicapsys Life Sciences (VICP, $0.44) was a top loser over the last three months, falling -7 to $0.44 per share. A.I.dvisor analyzed 911 stocks in the Biotechnology Industry for the 3-month period ending May 7, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.